Are you Dr. Zarzour?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 60 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Maria (Flores) Zarzour, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Louisiana, and Alabama. She is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2006 - 2009
- The University of Texas Health Science Center at San AntonioClass of 2006
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- TX State Medical License 2009 - 2025
- TN State Medical License 2023 - 2025
- LA State Medical License 2023 - 2024
- OK State Medical License 2020 - 2024
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Safety and efficacy of percutaneous image-guided ablation for soft tissue sarcoma metastases to the liver.Ahmed Awad, Koustav Pal, Steven Yevich, Joshua D Kuban, Alda Tam, Bruno C Odisio, Sanjay Gupta, Peiman Habibollahi, Andrew J Bishop, Anthony Paul Conley, Neeta Somaiah...> ;Cancer. 2024 Apr 20
- Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?Prapassorn Thirasastr, Thomas L Sutton, Cissimol P Joseph, Heather Lin, Behrang Amini, Skye C Mayo, Dejka Araujo, Robert S Benjamin, Anthony P Conley, John A Livingsto...> ;Cancers. 2024 Feb 23
- Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.Conley, A. P., Denu, R., Yang, R., Lazar, A., Patel, S., Lewis, V., Roszik, J., Livingston, J., Wang, W., Shaw, K., Ratan, R., Zarzour, M., Bird, J., Raza, S., Akdemir...> ;Clinical Cancer Research. 2023 Dec 1
- Join now to see all
Press Mentions
- Liposarcoma Survivor: Cancer Won’t Stop Me from Achieving My GoalsSeptember 20th, 2018
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas